• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

Peter M. Black, MD, PhD


  • Astrakas L, Blekas KD, Constantinou C, Andronesi OC, Mindrinos MN, Likas AC, Rahme LG, Black PM, Marcus KJ, Tzika AA.Combining magnetic resonance spectroscopy and molecular genomics offers better accuracy in brain tumor typing and prediction of survival than either methodology alone.Int J Oncol. 2011 Apr;38(4):1113-27.
  • Pohl KM, Konukoglu E, Novellas S, Ayache N, Fedorov A, Talos IF, Golby A, Wells WM, Kikinis R, Black PM.A new metric for detecting change in slowly evolving brain tumors: validation in meningioma patients.Neurosurgery. 2011 Mar;68(1 Suppl Operative):225-33.
  • Bassig BA, Inskip PD, Burdette L, Shapiro WR, Selker RG, Fine HA, Loeffler JS, Black PM, Dubrow R, Brenner AV.Selected human leukocyte antigen class II polymorphisms and risk of adult glioma.J Neuroimmunol. 2010 Dec 30.
  • Black P, Jolesz FA, Medani K.From Vision to Reality: The Origins of Intraoperative MR Imaging.Acta Neurochir. Suppl. 2011;109:3-7.
  • Black PM, Heros R, Morcos J, Brotchi J, .The XIV World Congress of Neurosurgery: August 30-September 4, 2009, Boston, Massachusetts.World Neurosurg. 2010 Apr;73(4):242-4.
  • Goutagny S, Yang HW, Zucman-Rossi J, Chan J, Dreyfuss JM, Park PJ, Black PM, Giovannini M, Carroll RS, Kalamarides M.Genomic profiling reveals alternative genetic pathways of meningioma malignant progression dependent on the underlying NF2 status.Clin Cancer Res. 2010 Aug 15;16(16):4155-64.
  • Yang HW, Menon LG, Black PM, Carroll RS, Johnson MD.SNAI2/Slug promotes growth and invasion in human gliomas.BMC Cancer. 2010;10:301.
  • Arai T, Benny O, Joki T, Menon LG, Machluf M, Abe T, Carroll RS, Black PM.Novel local drug delivery system using thermoreversible gel in combination with polymeric microspheres or liposomes.Anticancer Res. 2010 Apr;30(4):1057-64.
  • Agar NY, Malcolm JG, Mohan V, Yang HW, Johnson MD, Tannenbaum A, Agar JN, Black PM.Imaging of Meningioma Progression by Matrix-Assisted Laser Desorption Ionization Time-of-Flight Mass Spectrometry.Anal Chem. 2010 Apr 1;82(7):2621-5.
  • Lee JW, Wen PY, Hurwitz S, Black P, Kesari S, Drappatz J, Golby AJ, Wells WM, Warfield SK, Kikinis R, Bromfield EB.Morphological characteristics of brain tumors causing seizures.Arch Neurol. 2010 Mar;67(3):336-42.
  • Schmidt NO, Ziu M, Cargioli T, Westphal M, Giese A, Black PM, Carroll RS.Inhibition of thromboxane synthase activity improves glioblastoma response to alkylation chemotherapy.Transl Oncol. 2010 Feb;3(1):43-9.
  • Rajaraman P, Hutchinson A, Wichner S, Black PM, Fine HA, Loeffler JS, Selker RG, Shapiro WR, Rothman N, Linet MS, Inskip PD.DNA repair gene polymorphisms and risk of adult meningioma, glioma, and acoustic neuroma.Neuro Oncology. 2010 Jan;12(1):37-48.
  • Righi V, Andronesi OC, Mintzopoulos D, Black PM, Tzika AA.High-resolution magic angle spinning magnetic resonance spectroscopy detects glycine as a biomarker in brain tumors.Int J Oncol. 2010 Feb;36(2):301-6.
  • Mislow JM, Golby AJ, Black PM.Origins of intraoperative MRI.Magn Reson Imaging Clin N Am. 2010 Feb;18(1):1-10.
  • Menon LG, Kelly K, Yang HW, Kim SK, Black PM, Carroll RS.Human bone marrow-derived mesenchymal stromal cells expressing S-TRAIL as a cellular delivery vehicle for human glioma therapy.Stem Cells. 2009 Sep;27(9):2320-30.
  • Lee DH, Ahn Y, Kim SU, Wang KC, Cho BK, Phi JH, Park IH, Black PM, Carroll RS, Lee J, Kim SK.Targeting rat brainstem glioma using human neural stem cells and human mesenchymal stem cells.Clin Cancer Res. 2009 Aug 1;15(15):4925-34.
  • Mislow JM, Golby AJ, Black PM.Origins of intraoperative MRI.Neurosurg Clin N Am. 2009 Apr;20(2):137-46.
  • Coble JB,Dosemeci M,Stewart PA,Blair A,Bowman J,Fine HA,Shapiro WR,Selker RG,Loeffler JS,Black PM,Linet MS,Inskip PD.Occupational exposure to magnetic fields and the risk of brain tumors.Neuro-oncol. 2009 Jun;11(3):242-9.
  • Schmidt NO,Koeder D,Messing M,Mueller FJ,Aboody KS,Kim SU,Black PM,Carroll RS,Westphal M,Lamszus K.Vascular endothelial growth factor-stimulated cerebral microvascular endothelial cells mediate the recruitment of neural stem cells to the neurovascular niche.Brain Res. 2009 May 1;1268:24-37.
  • Benny O,Menon LG,Ariel G,Goren E,Kim SK,Stewman C,Black PM,Carroll RS,Machluf M.Local delivery of poly lactic-co-glycolic acid microspheres containing imatinib mesylate inhibits intracranial xenograft glioma growth.Clin Cancer Res. 2009 Feb 15;15(4):1222-31.
  • Kesari S,Schiff D,Drappatz J,LaFrankie D,Doherty L,Macklin EA,Muzikansky A,Santagata S,Ligon KL,Norden AD,Ciampa A,Bradshaw J,Levy B,Radakovic G,Ramakrishna N,Black PM,Wen PY.Phase II study of protracted daily temozolomide for low-grade gliomas in adults.Clin Cancer Res. 2009 Jan 1;15(1):330-7.
  • Black PC, Brown GA, Dinney CP.The impact of variant histology on the outcome of bladder cancer treated with curative intent.Urol Oncol.;27(1):3-7. Review.
  • Andronesi OC,Blekas KD,Mintzopoulos D,Astrakas L,Black PM,Tzika AA.Molecular classification of brain tumor biopsies using solid-state magic angle spinning proton magnetic resonance spectroscopy and robust classifiers.Int J Oncol. 2008 Nov;33(5):1017-25.
  • Shillito J,Black PM.The Harvard Neurosurgical Service at the Children's Hospital Boston and Brigham & Women's Hospital, 1912-2007.Neurosurgery. 2008 Sep;63(3):579-93; discussion 593.
  • Morokoff AP,Zauberman J,Black PM.Surgery for convexity meningiomas.Neurosurgery. 2008 Sep;63(3):427-33; discussion 433-4.
  • Tailor JK,Kim AH,Folkerth RD,Black PM.The development of ring-shaped contrast enhancement in a case of cerebellar dysembryoplastic neuroepithelial tumor: case report.Neurosurgery. 2008 Sep;63(3):E609-10; discussion E610.
  • Bracht LK,Wen P,Meyerhardt JA,Kulke MH,Hornick JL,Redston M,LaFrankie DC,Black PM,Kesari S,Norden A,Drappatz J.DNA repair enzyme expression and differential response to temozolomide in a patient with both glioblastoma and metastatic pancreatic neuroendocrine tumor.J Clin Oncol. 2008 Oct 10;26(29):4843-4.
  • Black PM,Morokoff AP,Zauberman J.Surgery for extra-axial tumors of the cerebral convexity and midline.Neurosurgery. 2008 Jun;62(6 Suppl 3):1115-21; discussion 1121-3. Review.
  • Rajaraman P,Hutchinson A,Rothman N,Black PM,Fine HA,Loeffler JS,Selker RG,Shapiro WR,Linet MS,Inskip PD.Oxidative response gene polymorphisms and risk of adult brain tumors.Neuro-oncol. 2008 Oct;10(5):709-15.
  • Kesari S, Schiff D, Henson JW, Muzikansky A, Gigas DC, Doherty L, Batchelor TT, Longtine JA, Ligon KL, Weaver S, Laforme A, Ramakrishna N, Black PM, Drappatz J, Ciampa A, Folkman J, Kieran M, Wen PY.Phase II study of temozolomide, thalidomide, and celecoxib for newly diagnosed glioblastoma in adults.Neuro-oncol. 2008 Jun;10(3):300-8.
  • Lonn S,Rothman N,Shapiro WR,Fine HA,Selker RG,Black PM,Loeffler JS,Hutchinson AA,Inskip PD.Genetic variation in insulin-like growth factors and brain tumor risk.Neuro-oncol. 2008 Aug;10(4):553-9.
  • Andronesi OC,Mintzopoulos D,Struppe J,Black PM,Tzika AA.Solid-state NMR adiabatic TOBSY sequences provide enhanced sensitivity for multidimensional high-resolution magic-angle-spinning 1H MR spectroscopy.J Magn Reson. 2008 Aug;193(2):251-8.
  • Drappatz J,Wong ET,Schiff D,Kesari S,Batchelor TT,Doherty L,Lafrankie DC,Ramakrishna N,Weiss S,Smith ST,Ciampa A,Zimmerman J,Ostrowsky L,David K,Norden A,Barron L,Sceppa C,Black PM,Wen PY.A pilot safety study of lenalidomide and radiotherapy for patients with newly diagnosed glioblastoma multiforme.Int J Radiat Oncol Biol Phys. 2009 Jan 1;73(1):222-7.
  • Konya D, Liao WL, Choi H, Yu D, Woodard MC, Newton KM, King AM, Pamir NM, Black PM, Frontera WR, Sabharwal S, Teng YD.Functional recovery in T13-L1 hemisected rats resulting from peripheral nerve rerouting: role of central neuroplasticity.Regen Med. 2008 May;3(3):309-27.
  • Archip N, Clatz O, Whalen S, Dimaio SP, Black PM, Jolesz FA, Golby A, Warfield SK.Compensation of geometric distortion effects on intraoperative magnetic resonance imaging for enhanced visualization in image-guided neurosurgery.Neurosurgery. 2008 Mar;62(3 Suppl 1):209-15; discussion 215-6.
  • Black P.Ensuring a holistic catchphrase of reform.Br J Nurs. 2008 Feb 28-Mar 12;17(4):217.
  • Black PC, Dinney CP.Growth factors and receptors as prognostic markers in urothelial carcinoma.Current Urology Reports. 2008 Jan;9(1):55-61. Review.
  • Talos DM, Kwiatkowski DJ, Cordero K, Black PM, Jensen FE.Cell-specific alterations of glutamate receptor expression in tuberous sclerosis complex cortical tubers.Ann Neurol. 2008 Apr;63(4):454-65.
  • Black PC, Brown GA, Inamoto T, Shrader M, Arora A, Siefker-Radtke AO, Adam L, Theodorescu D, Wu X, Munsell MF, Bar-Eli M, McConkey DJ, Dinney CP.Sensitivity to epidermal growth factor receptor inhibitor requires E-cadherin expression in urothelial carcinoma cells.Clin Cancer Res. 2008 Mar 1;14(5):1478-86.
  • Akar S, Drappatz J, Hsu L, Blinder RA, Black PM, Kesari S.Hypertrophic olivary degeneration after resection of a cerebellar tumor.J Neurooncol. 2008 May;87(3):341-345.
  • Claus EB, Park PJ, Carroll R, Chan J, Black PM.Specific genes expressed in association with progesterone receptors in meningioma.Cancer Res. 2008 Jan 1;68(1):314-22.
  • Agarwal PK, Black PC, Kamat AM.Considerations on the use of diagnostic markers in management of patients with bladder cancer.World J Urol. 2008 Feb;26(1):39-44. Review.
  • Bailey A, Black P.Which do you want first: the good news or the bad?.Br J Nurs. 2007 Oct 25-Nov 7;16(19):1175.
  • Kassouf W, Black PC, Tuziak T, Bondaruk J, Lee S, Brown GA, Adam L, Wei C, Baggerly K, Bar-Eli M, McConkey D, Czerniak B, Dinney CP.Distinctive expression pattern of ErbB family receptors signifies an aggressive variant of bladder cancer.J Urol. 2008 Jan;179(1):353-8.
  • Kirsch M, Allende R, Black P, Schackert G.Endogenous growth inhibition of angiogenesis in brain tumors.Cancer Metastasis Rev. 2007 Dec;26(3-4):469-79.
  • Wright JL, Black PC, Brown GA, Porter MP, Kamat AM, Dinney CP, Lin DW.Differences in survival among patients with sarcomatoid carcinoma, carcinosarcoma and urothelial carcinoma of the bladder.J Urol. 2007 Dec;178(6):2302-6; discussion 2307.
  • Kalamarides M, Stemmer-Rachamimov AO, Takahashi M, Han ZY, Chareyre F, Niwa-Kawakita M, Black PM, Carroll RS, Giovannini M.Natural history of meningioma development in mice reveals: a synergy of Nf2 and p16(Ink4a) mutations.Brain Pathol. 2008 Jan;18(1):62-70.
  • Kesari S, Schiff D, Doherty L, Gigas DC, Batchelor TT, Muzikansky A, O'neill A, Drappatz J, Chen-Plotkin AS, Ramakrishna N, Weiss SE, Levy B, Bradshaw J, Kracher J, Laforme A, Black PM, Folkman J, Kieran M, Wen PY.Phase II study of metronomic chemotherapy for recurrent malignant gliomas in adults.Neuro-oncol. 2007 Jul;9(3):354-63.
  • Ugur HC, Ramakrishna N, Bello L, Menon LG, Kim SK, Black PM, Carroll RS.Continuous intracranial administration of suberoylanilide hydroxamic acid (SAHA) inhibits tumor growth in an orthotopic glioma model.J Neurooncol. 2007 Jul;83(3):267-75.
  • Smith ER, Manfredi M, Scott RM, Black PM, Moses MA.A recurrent craniopharyngioma illustrates the potential usefulness of urinary matrix metalloproteinases as noninvasive biomarkers: case report.Neurosurgery. 2007 Jun;60(6):E1148-9; discussion E1149.
  • Ngo TT, Peng T, Liang XJ, Akeju O, Pastorino S, Zhang W, Kotliarov Y, Zenklusen JC, Fine HA, Maric D, Wen PY, De Girolami U, Black PM, Wu WW, Shen RF, Jeffries NO, Kang DW, Park JK.The 1p-encoded protein stathmin and resistance of malignant gliomas to nitrosoureas.Journal of the National Cancer Institute. 2007 Apr 18;99(8):639-52.
  • Cargioli TG, Ugur HC, Ramakrishna N, Chan J, Black PM, Carroll RS.Establishment of an in vivo meningioma model with human telomerase reverse transcriptase.Neurosurgery. 2007 Apr;60(4):750-9; discussion 759-60.
  • Archip N, Clatz O, Whalen S, Kacher D, Fedorov A, Kot A, Chrisochoides N, Jolesz F, Golby A, Black PM, Warfield SK.Non-rigid alignment of pre-operative MRI, fMRI, and DT-MRI with intra-operative MRI for enhanced visualization and navigation in image-guided neurosurgery.Neuroimage. 2007 Apr 1;35(2):609-24.
  • Marcus KJ, Astrakas LG, Zurakowski D, Zarifi MK, Mintzopoulos D, Poussaint TY, Anthony DC, De Girolami U, Black PM, Tarbell NJ, Tzika AA.Predicting survival of children with CNS tumors using proton magnetic resonance spectroscopic imaging biomarkers.Int J Oncol. 2007 Mar;30(3):651-7.
  • Yu Y, Jiang X, Schoch BS, Carroll RS, Black PM, Johnson MD.Aberrant splicing of cyclin-dependent kinase-associated protein phosphatase KAP increases proliferation and migration in glioblastoma.Cancer Res. 2007 Jan 1;67(1):130-8.
  • Rajaraman P, Stewart PA, Samet JM, Schwartz BS, Linet MS, Zahm SH, Rothman N, Yeager M, Fine HA, Black PM, Loeffler J, Shapiro WR, Selker RG, Inskip PD.Lead, genetic susceptibility, and risk of adult brain tumors.Cancer Epidemiol Biomarkers Prev. 2006 Dec;15(12):2514-20.
  • Santagata S, Kesari S, Black PM, Chan JA.Anaplastic variant of medulloblastoma mimicking a vestibular schwannoma.J Neurooncol. 2007 Jan;81(1):49-51.
  • Maher EA, Brennan C, Wen PY, Durso L, Ligon KL, Richardson A, Khatry D, Feng B, Sinha R, Louis DN, Quackenbush J, Black PM, Chin L, DePinho RA.Marked genomic differences characterize primary and secondary glioblastoma subtypes and identify two distinct molecular and clinical secondary glioblastoma entities.Cancer Res. 2006 Dec 1;66(23):11502-13.
  • Liu F, Park PJ, Lai W, Maher E, Chakravarti A, Durso L, Jiang X, Yu Y, Brosius A, Thomas M, Chin L, Brennan C, DePinho RA, Kohane I, Carroll RS, Black PM, Johnson MD.A genome-wide screen reveals functional gene clusters in the cancer genome and identifies EphA2 as a mitogen in glioblastoma.Cancer Res. 2006 Nov 15;66(22):10815-23.
  • Bluhm EC, Zahm SH, Fine HA, Black PM, Loeffler JS, Shapiro WR, Selker RG, Inskip PD.Personal hair dye use and risks of glioma, meningioma, and acoustic neuroma among adults.Am J Epidemiol. 2007 Jan 1;165(1):63-71.
  • Dimaio SP, Archip N, Hata N, Talos IF, Warfield SK, Majumdar A, Mcdannold N, Hynynen K, Morrison PR, Wells WM, Kacher DF, Ellis RE, Golby AJ, Black PM, Jolesz FA, Kikinis R.Image-guided neurosurgery at Brigham and Women's Hospital.IEEE Eng Med Biol Mag. 2006 Sep-Oct;25(5):67-73.
  • Kim SK, Kim SU, Park IH, Bang JH, Aboody KS, Wang KC, Cho BK, Kim M, Menon LG, Black PM, Carroll RS.Human neural stem cells target experimental intracranial medulloblastoma and deliver a therapeutic gene leading to tumor regression.Clin Cancer Res. 2006 Sep 15;12(18):5550-6.
  • Ziu M, Schmidt NO, Cargioli TG, Aboody KS, Black PM, Carroll RS.Glioma-produced extracellular matrix influences brain tumor tropism of human neural stem cells.J Neurooncol. 2006 Sep;79(2):125-33.
  • Chakravarti A, Erkkinen MG, Nestler U, Stupp R, Mehta M, Aldape K, Gilbert MR, Black PM, Loeffler JS.Temozolomide-mediated radiation enhancement in glioblastoma: a report on underlying mechanisms.Clin Cancer Res. 2006 Aug 1;12(15):4738-46.
  • Talos IF, Zou KH, Ohno-Machado L, Bhagwat JG, Kikinis R, Black PM, Jolesz FA.Supratentorial low-grade glioma resectability: statistical predictive analysis based on anatomic MR features and tumor characteristics.Radiology. 2006 May;239(2):506-13.
  • De Roos AJ, Rothman N, Brown M, Bell DA, Pittman GS, Shapiro WR, Selker RG, Fine HA, Black PM, Inskip PD.Variation in genes relevant to aromatic hydrocarbon metabolism and the risk of adult brain tumors.Neuro-oncol. 2006 Apr;8(2):145-55.
  • Black PM.Challenges in contemporary academic neurosurgery.Neurosurgery. 2006 Mar;58(3):419-25; discussion 419-25.
  • Aboody KS, Najbauer J, Schmidt NO, Yang W, Wu JK, Zhuge Y, Przylecki W, Carroll R, Black PM, Perides G.Targeting of melanoma brain metastases using engineered neural stem/progenitor cells.Neuro-oncol. 2006 Apr;8(2):119-26.
  • Knake S, Halgren E, Shiraishi H, Hara K, Hamer HM, Grant PE, Carr VA, Foxe D, Camposano S, Busa E, Witzel T, Hamalainen MS, Ahlfors SP, Bromfield EB, Black PM, Bourgeois BF, Cole AJ, Cosgrove GR, Dworetzky BA, Madsen JR, Larsson PG, Schomer DL, Thiele EA, Dale AM, Rosen BR, Stufflebeam SM.The value of multichannel MEG and EEG in the presurgical evaluation of 70 epilepsy patients.Epilepsy Res. 2006 Apr;69(1):80-6.
  • Claus EB, Black PM.Survival rates and patterns of care for patients diagnosed with supratentorial low-grade gliomas: data from the SEER program, 1973-2001.Cancer. 2006 Mar 15;106(6):1358-63.
  • Claus EB, Bondy ML, Schildkraut JM, Wiemels JL, Wrensch M, Black PM.Epidemiology of intracranial meningioma.Neurosurgery. 2005 Dec;57(6):1088-95; discussion 1088-.
  • Brenner AV, Linet MS, Shapiro WR, Selker RG, Fine HA, Black PM, Inskip PD.Season of birth and risk of brain tumors in adults.Neurology. 2004 Jul 27;63(2):276-81.
  • Chakravarti A, Zhai G, Suzuki Y, Sarkesh S, Black PM, Muzikansky A, Loeffler JS.The prognostic significance of phosphatidylinositol 3-kinase pathway activation in human gliomas.J Clin Oncol. 2004 May 15;22(10):1926-33.
  • Tzika AA, Astrakas LG, Zarifi MK, Zurakowski D, Poussaint TY, Goumnerova L, Tarbell NJ, Black PM.Spectroscopic and perfusion magnetic resonance imaging predictors of progression in pediatric brain tumors.Cancer. 2004 Mar 15;100(6):1246-56.
  • Schmidt NO, Ziu M, Carrabba G, Giussani C, Bello L, Sun Y, Schmidt K, Albert M, Black PM, Carroll RS.Antiangiogenic therapy by local intracerebral microinfusion improves treatment efficiency and survival in an orthotopic human glioblastoma model.Clin Cancer Res. 2004 Feb 15;10(4):1255-62.
  • Hill DA, Inskip PD, Shapiro WR, Selker RG, Fine HA, Black PM, Linet MS.Cancer in first-degree relatives and risk of glioma in adults.Cancer Epidemiol Biomarkers Prev. 2003 Dec;12(12):1443-8.
  • De Roos AJ, Stewart PA, Linet MS, Heineman EF, Dosemeci M, Wilcosky T, Shapiro WR, Selker RG, Fine HA, Black PM, Inskip PD.Occupation and the risk of adult glioma in the United States.Cancer Causes Control. 2003 Mar;14(2):139-50.
  • Inskip PD, Tarone RE, Hatch EE, Wilcosky TC, Fine HA, Black PM, Loeffler JS, Shapiro WR, Selker RG, Linet MS.Sociodemographic indicators and risk of brain tumours.Int J Epidemiol. 2003 Apr;32(2):225-33.
  • Nutt CL, Mani DR, Betensky RA, Tamayo P, Cairncross JG, Ladd C, Pohl U, Hartmann C, McLaughlin ME, Batchelor TT, Black PM, von Deimling A, Pomeroy SL, Golub TR, Louis DN.Gene expression-based classification of malignant gliomas correlates better with survival than histological classification.Cancer Res. 2003 Apr 1;63(7):1602-7.
  • Inskip PD, Tarone RE, Brenner AV, Fine HA, Black PM, Shapiro WR, Selker RG, Linet MS.Handedness and risk of brain tumors in adults.Cancer Epidemiol Biomarkers Prev. 2003 Mar;12(3):223-5.
  • Inskip PD, Tarone RE, Hatch EE, Wilcosky TC, Selker RG, Fine HA, Black PM, Loeffler JS, Shapiro WR, Linet MS.Laterality of brain tumors.Neuroepidemiology. 2003 Mar-Apr;22(2):130-8.
  • Brenner AV, Linet MS, Selker RG, Shapiro WR, Black PM, Fine HA, Inskip PD.Polio vaccination and risk of brain tumors in adults: no apparent association.Cancer Epidemiol Biomarkers Prev. 2003 Feb;12(2):177-8.
  • Nabavi A, Gering DT, Kacher DF, Talos IF, Wells WM, Kikinis R, Black PM, Jolesz FA.Surgical navigation in the open MRI.Acta Neurochir Suppl. 2003;85:121-5.
  • De Roos AJ, Rothman N, Inskip PD, Linet MS, Shapiro WR, Selker RG, Fine HA, Black PM, Pittman GS, Bell DA.Genetic polymorphisms in GSTM1, -P1, -T1, and CYP2E1 and the risk of adult brain tumors.Cancer Epidemiol Biomarkers Prev. 2003 Jan;12(1):14-22.
  • Tzika AA, Astrakas LG, Zarifi MK, Petridou N, Young-Poussaint T, Goumnerova L, Zurakowski D, Anthony DC, Black PM.Multiparametric MR assessment of pediatric brain tumors.Neuroradiology. 2003 Jan;45(1):1-10.
  • Black P, Jaaskelainen J, Chabrerie A, Golby A, Gugino L.Minimalist approach: functional mapping.Clin Neurosurg. 2002;49:90-102.
  • Bello L, Lucini V, Giussani C, Carrabba G, Pluderi M, Scaglione F, Tomei G, Villani R, Black PM, Bikfalvi A, Carroll RS.IS20I, a specific alphavbeta3 integrin inhibitor, reduces glioma growth in vivo.Neurosurgery. 2003 Jan;52(1):177-85; discussion 185-6.
  • Ferrant M, Nabavi A, Macq B, Black PM, Jolesz FA, Kikinis R, Warfield SK.Serial registration of intraoperative MR images of the brain.Med Image Anal. 2002 Dec;6(4):337-59.
  • Tzika AA, Cheng LL, Goumnerova L, Madsen JR, Zurakowski D, Astrakas LG, Zarifi MK, Scott RM, Anthony DC, Gonzalez RG, Black PM.Biochemical characterization of pediatric brain tumors by using in vivo and ex vivo magnetic resonance spectroscopy.J Neurosurg. 2002 Jun;96(6):1023-31.
  • Brenner AV, Linet MS, Fine HA, Shapiro WR, Selker RG, Black PM, Inskip PD.History of allergies and autoimmune diseases and risk of brain tumors in adults.Int J Cancer. 2002 May 10;99(2):252-9.
  • Tan TC, Black PM.The contributions of Otfrid Foerster (1873-1941) to neurology and neurosurgery.Neurosurgery. 2001 Nov;49(5):1231-5; discussion 1235-6.
  • Tzika AA, Zarifi MK, Goumnerova L, Astrakas LG, Zurakowski D, Young-Poussaint T, Anthony DC, Scott RM, Black PM.Neuroimaging in pediatric brain tumors: Gd-DTPA-enhanced, hemodynamic, and diffusion MR imaging compared with MR spectroscopic imaging.AJNR Am J Neuroradiol. 2002 Feb;23(2):322-33.
  • Chakravarti A, Noll E, Black PM, Finkelstein DF, Finkelstein DM, Dyson NJ, Loeffler JS.Quantitatively determined survivin expression levels are of prognostic value in human gliomas.J Clin Oncol. 2002 Feb 15;20(4):1063-8.
  • Pomeroy SL, Tamayo P, Gaasenbeek M, Sturla LM, Angelo M, McLaughlin ME, Kim JY, Goumnerova LC, Black PM, Lau C, Allen JC, Zagzag D, Olson JM, Curran T, Wetmore C, Biegel JA, Poggio T, Mukherjee S, Rifkin R, Califano A, Stolovitzky G, Louis DN, Mesirov JP, Lander ES, Golub TR.Prediction of central nervous system embryonal tumour outcome based on gene expression.Nature. 2002 Jan 24;415(6870):436-42.
  • Bello L, Lucini V, Carrabba G, Giussani C, Machluf M, Pluderi M, Nikas D, Zhang J, Tomei G, Villani RM, Carroll RS, Bikfalvi A, Black PM.Simultaneous inhibition of glioma angiogenesis, cell proliferation, and invasion by a naturally occurring fragment of human metalloproteinase-2.Cancer Res. 2001 Dec 15;61(24):8730-6.
  • Kirsch M, Santarius T, Black PM, Schackert G.Therapeutic anti-angiogenesis for malignant brain tumors.Onkologie. 2001 Oct;24(5):423-30.
  • Bello L, Carrabba G, Giussani C, Lucini V, Cerutti F, Scaglione F, Landré J, Pluderi M, Tomei G, Villani R, Carroll RS, Black PM, Bikfalvi A.Low-dose chemotherapy combined with an antiangiogenic drug reduces human glioma growth in vivo.Cancer Res. 2001 Oct 15;61(20):7501-6.
  • Lu QR, Park JK, Noll E, Chan JA, Alberta J, Yuk D, Alzamora MG, Louis DN, Stiles CD, Rowitch DH, Black PM.Oligodendrocyte lineage genes (OLIG) as molecular markers for human glial brain tumors.Proc Natl Acad Sci U S A. 2001 Sep 11;98(19):10851-6.
  • Bello L, Francolini M, Marthyn P, Zhang J, Carroll RS, Nikas DC, Strasser JF, Villani R, Cheresh DA, Black PM.Alpha(v)beta3 and alpha(v)beta5 integrin expression in glioma periphery.Neurosurgery. 2001 Aug;49(2):380-9; discussion 390.
  • Chakravarti A, Delaney MA, Noll E, Black PM, Loeffler JS, Muzikansky A, Dyson NJ.Prognostic and pathologic significance of quantitative protein expression profiling in human gliomas.Clin Cancer Res. 2001 Aug;7(8):2387-95.
  • Tzika AA, Zurakowski D, Poussaint TY, Goumnerova L, Astrakas LG, Barnes PD, Anthony DC, Billett AL, Tarbell NJ, Scott RM, Black PM.Proton magnetic spectroscopic imaging of the child's brain: the response of tumors to treatment.Neuroradiology. 2001 Feb;43(2):169-77.
  • Nabavi A, Black PM, Gering DT, Westin CF, Mehta V, Pergolizzi RS, Ferrant M, Warfield SK, Hata N, Schwartz RB, Wells WM, Kikinis R, Jolesz FA.Serial intraoperative magnetic resonance imaging of brain shift.Neurosurgery. 2001 Apr;48(4):787-97; discussion 797-8.
  • Cheng LL, Anthony DC, Comite AR, Black PM, Tzika AA, Gonzalez RG.Quantification of microheterogeneity in glioblastoma multiforme with ex vivo high-resolution magic-angle spinning (HRMAS) proton magnetic resonance spectroscopy.Neuro-oncol. 2000 Apr;2(2):87-95.
  • Noll EN, Lin J, Nakatsuji Y, Miller RH, Black PM.GM3 as a novel growth regulator for human gliomas.Exp Neurol. 2001 Apr;168(2):300-9.
  • Dunn IF, Heese O, Black PM.Growth factors in glioma angiogenesis: FGFs, PDGF, EGF, and TGFs.J Neurooncol. 2000 Oct-Nov;50(1-2):121-37.
  • Black PM, Black CT.History of neurosurgery for intracranial mass lesions.Neurosurg Clin N Am. 2001 Jan;12(1):1-9, vii.
  • Kaus MR, Warfield SK, Nabavi A, Black PM, Jolesz FA, Kikinis R.Automated segmentation of MR images of brain tumors.Radiology. 2001 Feb;218(2):586-91.
  • Inskip PD, Tarone RE, Hatch EE, Wilcosky TC, Shapiro WR, Selker RG, Fine HA, Black PM, Loeffler JS, Linet MS.Cellular-telephone use and brain tumors.N Engl J Med. 2001 Jan 11;344(2):79-86.
  • Joki T, Carroll RS, Dunn IF, Zhang J, Abe T, Black PM.Assessment of alterations in gene expression in recurrent malignant glioma after radiotherapy using complementary deoxyribonucleic acid microarrays.Neurosurgery. 2001 Jan;48(1):195-201; discussion 201-2.
  • Joki T, Machluf M, Atala A, Zhu J, Seyfried NT, Dunn IF, Abe T, Carroll RS, Black PM.Continuous release of endostatin from microencapsulated engineered cells for tumor therapy.Nat Biotechnol. 2001 Jan;19(1):35-9.
  • Chan AW, Tarbell NJ, Black PM, Louis DN, Frosch MP, Ancukiewicz M, Chapman P, Loeffler JS.Adult medulloblastoma: prognostic factors and patterns of relapse.Neurosurgery. 2000 Sep;47(3):623-31; discussion 631-2.
  • Bouterfa H, Picht T, Kess D, Herbold C, Noll E, Black PM, Roosen K, Tonn JC.Retinoids inhibit human glioma cell proliferation and migration in primary cell cultures but not in established cell lines.Neurosurgery. 2000 Feb;46(2):419-30.
  • Carroll RS, Zhang J, Bello L, Melnick MB, Maruyama T, McL Black P.KDR activation in astrocytic neoplasms.Cancer. 1999 Oct 1;86(7):1335-41.
  • Black PM, Alexander E, Martin C, Moriarty T, Nabavi A, Wong TZ, Schwartz RB, Jolesz F.Craniotomy for tumor treatment in an intraoperative magnetic resonance imaging unit.Neurosurgery. 1999 Sep;45(3):423-31; discussion 431-3.
  • Carroll RS, Zhang J, Black PM.Expression of estrogen receptors alpha and beta in human meningiomas.J Neurooncol. 1999 Apr;42(2):109-16.
  • Ozlen F, Nakajima S, Chabrerie A, Leventon ME, Grimson E, Kikinis R, Jolesz F, Black PM.Excision of cortical dysplasia in the language area with use of a surgical navigator: a case report.Epilepsia. 1998 Dec;39(12):1361-6.
  • Mitsumori M, Shrieve DC, Alexander E, Kaiser UB, Richardson GE, Black PM, Loeffler JS.Initial clinical results of LINAC-based stereotactic radiosurgery and stereotactic radiotherapy for pituitary adenomas.Int J Radiat Oncol Biol Phys. 1998 Oct 1;42(3):573-80.
  • Kettenbach J, Silverman SG, Hata N, Kuroda K, Saiviroonporn P, Zientara GP, Morrison PR, Hushek SG, Black PM, Kikinis R, Jolesz FA.Monitoring and visualization techniques for MR-guided laser ablations in an open MR system.J Magn Reson Imaging. 1998 Jul-Aug;8(4):933-43.
  • Kassis AI, Wen PY, Van den Abbeele AD, Baranowska-Kortylewicz J, Makrigiorgos GM, Metz KR, Matalka KZ, Cook CU, Sahu SK, Black PM, Adelstein SJ.5-[125I]iodo-2'-deoxyuridine in the radiotherapy of brain tumors in rats.J Nucl Med. 1998 Jul;39(7):1148-54.
  • Chabrerie A, Ozlen F, Nakajima S, Leventon ME, Atsumi H, Grimson E, Keeve E, Helmers S, Riviello J, Holmes G, Duffy F, Jolesz F, Kikinis R, Black PM.Three-dimensional reconstruction and surgical navigation in pediatric epilepsy surgery.Pediatr Neurosurg. 1997 Dec;27(6):304-10.
  • Schwartz RB, Holman BL, Polak JF, Garada BM, Schwartz MS, Folkerth R, Carvalho PA, Loeffler JS, Shrieve DC, Black PM, Alexander E.Dual-isotope single-photon emission computerized tomography scanning in patients with glioblastoma multiforme: association with patient survival and histopathological characteristics of tumor after high-dose radiotherapy.J Neurosurg. 1998 Jul;89(1):60-8.
  • Le S, Zhu JJ, Anthony DC, Greider CW, Black PM.Telomerase activity in human gliomas.Neurosurgery. 1998 May;42(5):1120-4; discussion 1124-5.
  • Zhu JJ, Santarius T, Wu X, Tsong J, Guha A, Wu JK, Hudson TJ, Black PM.Screening for loss of heterozygosity and microsatellite instability in oligodendrogliomas.Genes Chromosomes Cancer. 1998 Mar;21(3):207-16.
  • Di Rocco F, Carroll RS, Zhang J, Black PM.Platelet-derived growth factor and its receptor expression in human oligodendrogliomas.Neurosurgery. 1998 Feb;42(2):341-6.
  • Black PM, Westphal M.Growth factors, glial cells and neuro-oncology. Perspectives for treatment?.J Neurooncol. 1997 Dec;35(3):189-90.
  • Carroll RS, Zhang J, Chauncey BW, Chantziara K, Frosch MP, Black PM.Apoptosis in astrocytic neoplasms.Acta Neurochir (Wien). 1997;139(9):845-50.
  • Carroll RS, Black PM, Zhang J, Kirsch M, Percec I, Lau N, Guha A.Expression and activation of epidermal growth factor receptors in meningiomas.J Neurosurg. 1997 Aug;87(2):315-23.
  • Kikinis R, Gleason PL, Moriarty TM, Moore MR, Alexander E, Stieg PE, Matsumae M, Lorensen WE, Cline HE, Black PM, Jolesz FA.Computer-assisted interactive three-dimensional planning for neurosurgical procedures.Neurosurgery. 1996 Apr;38(4):640-9; discussion 649-51.
  • Leon SP, Folkerth RD, Black PM.Microvessel density is a prognostic indicator for patients with astroglial brain tumors.Cancer. 1996 Jan 15;77(2):362-72.
  • Wen PY, Fine HA, Black PM, Shrieve DC, Alexander E, Loeffler JS.High-grade astrocytomas.Neurol Clin. 1995 Nov;13(4):875-900.